Quantitative histopathology identifies patients with thin melanomas who are at risk for metastases.

This research was supported in part by grants from the National Cancer Institute (P01 CA27502-33, and the Arizona Cancer Center Support Grant CA023074), Bethesda, MD. The authors also gratefully acknowledge support from The Jim Click Family Foundation, Tucson, Arizona, and the J. Russell Skelton Family, Phoenix, Arizona.